DNA - $44 Billion Buyout

07/21/2008 12:00 am EST


Thomas Aspray

, Professional Trader & Analyst

Roche's offer to buy remainder of Genetech (DNA) at $89 per share might explain the breakout on the weekly chart. This should give the market and biotech some support even though the price is not that much of a premium over last Friday's close.
  By clicking submit, you agree to our privacy policy & terms of service.

Related Articles on STOCKS

Keyword Image
Cognizant: From AI to IT
12 hours ago

Cognizant Technology Solutions (CTSH) began operations in 1994 as an in-house technology development...